Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2001, p. 2324-2330, Vol. 45, No. 8
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.8.2324-2330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Characterization of Chromosomal Class C
-Lactamase
and Its Regulatory Gene in Ochrobactrum
anthropi
David
Nadjar,1
Roger
Labia,2
Claude
Cerceau,2
Chantal
Bizet,3
Alain
Philippon,4 and
Guillaume
Arlet1,*
Laboratoire de Bactériologie,
Hôpital Tenon, UFR Saint-Antoine,1
Collection de l'Institut Pasteur, Institut
Pasteur,3 and Service de
Bactériologie, CHU Cochin,4 Paris, and
CNRS-UBO-MHN, Unité FRE 2125,
Quimper,2 France
Received 28 December 2000/Returned for modification 9 April
2001/Accepted 26 May 2001
 |
ABSTRACT |
Ochrobactrum anthropi, formerly known as CDC group Vd,
is an oxidase-producing, gram-negative, obligately aerobic,
non-lactose-fermenting bacillus of low virulence that occasionally
causes human infections. It is highly resistant to all
-lactams
except imipenem. A clinical isolate, SLO74, and six reference strains
were tested. MICs of penicillins, aztreonam, and most cephalosporins
tested, including cefotaxime and ceftazidime, were >128 µg/ml and of
cefepime were 64 to >128 µg/ml. Clavulanic acid was ineffective and
tazobactam had a weak effect in association with piperacillin. Two
genes, ampR and ampC, were cloned by inserting
restriction fragments of genomic DNA from the clinical strain O. anthropi SLO74 into pBK-CMV to give the recombinant plasmid
pBK-OA1. The pattern of resistance to
-lactams of this clone was
similar to that of the parental strain, except for its resistance to
cefepime (MIC, 0.5 µg/ml). The deduced amino acid sequence of the
AmpC
-lactamase (pI, 8.9) was only 41 to 52% identical to
the sequence of other chromosomally encoded and plasmid-encoded class C
-lactamases. The kinetic properties of this
-lactamase were typical for this class of
-lactamases. Upstream from the ampC gene,
the ampR gene encodes a protein with a sequence that is 46 to 62% identical to those of other AmpR proteins and with an
amino-terminal DNA-binding domain typical of transcriptional activators
of the Lys-R family. The deduced amino acid sequences of the
ampC genes of the six reference strains were 96 to 99%
identical to the sequence of the clinical strain. The
-lactamase characterized from strain SLO74 was named
OCH-1 (gene, blaOCH-I).
 |
INTRODUCTION |
The species of the genus
Ochrobactrum form two groups: Ochrobactrum
anthropi and O. intermedium (25). O. anthropi, formerly classified as CDC group Vd, is a nonfastidious,
gram-negative bacillus that is strictly aerobic, oxidase positive, and
motile (with peritrichous flagella), does not ferment lactose, and has strong urease activity (8, 16). O. anthropi is
widespread and is distributed in water and hospital environments. In
some cases, it has been isolated from water-based environments in
hospitals (antiseptic solutions, dialysis fluids) (12). It
has often been found on human clinical material: it often adheres to
catheters, but pacemakers, intraocular lenses, and silicon tubing may
also become infected (10, 18). Although only weakly
virulent, O. anthropi causes hospital-acquired infections,
often in immunocompromised hosts (7, 11, 14, 27). O. anthropi is usually resistant to
-lactams, such as
broad-spectrum penicillins and oxyimino cephalosporins, except for
cefepime in some cases and aztreonam (3). It is generally
susceptible to carbapenems and aminoglycosides (19), trimethoprim-sulfamethoxazole (4),
ciprofloxacin, and tetracyclines. The most effective antimicrobial
agents for treating human infections are imipenem,
trimethoprim-sulfamethoxazole, and ciprofloxacin (7),
sometimes in conjunction with catheter removal (28).
As this bacterium displays extensive resistance to
-lactams,
we screened for and cloned a
-lactamase gene.
 |
MATERIALS AND METHODS |
Bacterial strains.
Table 1
shows the bacterial strains used in this study. O. anthropi SLO74 was isolated in November 1991 at Saint-Louis
Hospital (Paris, France) from a blood culture from a leukemic patient
with catheter-related sepsis. Six reference strains of O. anthropi were obtained from the collection of the Pasteur
Institute (Paris, France). Escherichia coli XL1-Blue
(Stratagene, Amsterdam, The Netherlands) and E. coli HB101
(Bio-Rad, Marnes-La-Coquette, France) were used for cloning and
subcloning experiments, respectively.
Antimicrobial agents and MIC determination.
The
antimicrobial agents used were standard laboratory powders. The
antimicrobial agents used were as follows: amoxicillin, clavulanic
acid, and ticarcillin (SmithKline Beecham, Nanterre, France);
piperacillin and tazobactam (Wyeth-Lederle, Oullins, France);
cephalothin and cefamandole (Eli-Lilly, Saint-Cloud, France); cefepime
(Bristol-Myers Squibb, Nanterre, France); cefotaxime (Aventis, Paris,
France); cefoxitin and imipenem (Merck Sharp & Dohme-Chibret,
Paris, France); aztreonam (Sanofi, Paris, France); and
ceftazidime (GlaxoWellcome, Marly-le-Roy, France).
MICs were determined with the standard agar dilution technique on
Mueller-Hinton agar (Bio-Rad) with a multiple inoculator
and an
inoculum of 10
5 CFU per spot. All plates were incubated at
37°C for 18 h. The
MICs of some

-lactams (amoxicillin,
ticarcillin, and piperacillin)
were determined alone or in combination
with 2 µg of clavulanic
acid per ml or 4 µg of tazobactam per
ml.
Cloning experiments and recombinant plasmids.
The
chromosomal DNA of O. anthropi SLO74 was prepared as
described by Grimont and Grimont (13). It was digested
with EcoRI (Roche Biochemicals France S.A., Meylan, France)
and ligated using T4 DNA ligase (Amersham Pharmacia Biotech, Saclay,
France) into the EcoRI site of the pBK-CMV phagemid (Table
1) (Stratagene). Recombinant plasmids were introduced into E. coli XL1 by the standard CaCl2 technique.
Antibiotic-resistant colonies were selected on Drigaski agar (Bio-Rad)
containing ceftazidime (2 µg/ml) and kanamycin (25 µg/ml) (Sigma,
Saint-Quentin Falavier, France). Recombinant plasmid DNA was
recovered using Qiagen columns (Qiagen, Courtaboeuf, France), and
the size of the inserts was estimated by restriction enzyme digestion
and electrophoresis in 1 to 3% agarose gels.
The recombinant plasmid pBK-OA1 was double digested with
SacII (Roche Biochemicals) and
EcoRI, and the
resulting fragment
was ligated into the pBC SK
+ phagemid
(Table
1) (Stratagene) digested with the same enzymes.
Transformants
were selected on the basis of resistance to amoxicillin
(40 µg/ml)
and chloramphenicol (25 µg/ml) (Sigma) using Drigalski
agar
plates.
Preparation of crude extracts of
-lactamase.
The O. anthropi SLO74 strain and the six reference strains
of O. anthropi (Table 1) were cultured overnight at 37°C
in 100 ml of Trypticase soy broth. For cultures of the E. coli XL1(pBK-OA1) clone and the E. coli
HB101(pSK+-OA2) subclone, amoxicillin (40 µg/ml) and more
kanamycin (25 µg/ml) or more chloramphenicol (25 µg/ml),
respectively, were added to the medium to maintain selection pressure.
Bacterial suspensions were pelleted (30 min at 5,800 × g), resuspended in 2 ml of 20 mM Tris buffer (pH 7.5), and
disrupted by sonication (two times for 30 s each at 20 Hz) (Vibra
Cell; Bioblock Scientific, Illkirch, France). The crude extracts were
cleared by centrifugation at 48,000 × g for 30 min at
4°C.
IEF.
All
-lactamase extracts were subjected
to analytical isoelectric focusing (IEF) (1) on an
ampholine polyacrylamide gel with a pH range of 3.5 to 10. The gel was
put in a Multiphor apparatus (Amersham Pharmacia Biotech) for 18 h
at 200 V, 15 mA, and 6 W. The focused
-lactamases were
detected by overlaying the gel with 1 mM nitrocefin (Oxoid, Paris,
France). The pI markers were those for the reference
-lactamases: for TEM-3 (pCFF04), pI is 6.3; for SHV-4
(pUD21), pI is 7.8; and for CMY-2 (pSenf), pI is 9.2.
-Lactamase purification and kinetic measurements.
Cells
of the E. coli HB101 subclone containing the recombinant
plasmid pSK+-OA2 (Table 1) were obtained from 4-liter
cultures in brain heart infusion broth (Difco) at 37°C. Cells were
harvested by centrifugation at 5,800 × g for 30 min.
The pellets (about 12 g [wet weight]) were washed by
resuspending them in 24 ml of 0.15 M NaCl and centrifuging at
5,800 × g for 20 min. The supernatants were discarded
and the pellets were resuspended under the same conditions, lysed by
sonication (Branson Sonifier), and centrifuged at 5,800 × g for 1 h. The pellets were discarded. The crude extracts
were cleared by centrifugation at 48,000 × g for 30 min at 4°C. Nucleic acids were precipitated by adding spermine (0.2 M) (Sigma) and collected by centrifugation (30,000 × g
for 30 min at 4°C). The supernatant was dialyzed three times against
5 liters of distilled water and lyophilized. The enzyme was purified by
chromatography on Bio-Rex 70 resin (weakly acidic cation exchanger)
equilibrated with 10 mM Tris hydrochloride buffer, pH 7.0. The
-lactamase was eluted with a linear gradient of 0 to 0.6 M NaCl, and active fractions were pooled, desalted by three
centrifugations and dilutions on an Ultrafree-20 centrifuge filter unit
with a nominal molecular weight limit of 10,000 (Sigma), and used
rapidly for kinetic studies. The kinetic constants
kcat and Km for
substrates were determined by a computerized microacidimetric assay at
pH 7.0 and 37°C in 0.1 M NaCl as described by Labia et al.
(20). One
-lactamase unit is defined as the
amount of enzyme hydrolyzing 1 µmol of benzylpenicillin in 1 min at
pH 7.0 and 37°C. In this test, the initial benzylpenicillin
concentration is 500 µM.
DNA sequencing, PCR amplification, and sequence analysis.
The insert of the recombinant plasmid pBK-OA1 was sequenced using the
method of Sanger et al. (30), with fluorescent dye-labeled dideoxynucleotides, thermal cycling with Taq polymerase
(Amersham), and an ABI 373A DNA sequencer (Applied Biosystems,
Foster City, Calif.). We studied the variability of the ampC
genes of O. anthropi using two primers designed
to amplify the entire coding region in the six reference strains: upper
ochro (5'-AATTTTTCTAATGCCAAGTGCT-3') and lower ochro
(5'-GCCTATTGCTTGTTGTCGAG-3') (see Fig. 2). The PCR products
were sequenced and analyzed. The BLASTN program of NCBI
(http://www.ncbi.nlm.nih.gov) was used for database searches, and
Clustal W (http://www.2.eib.ac.uk./clustalw) was used to align multiple protein sequences.
Nucleotide sequence accession numbers.
The
blaOCH gene nucleotide sequence data appear in
the EMBL nucleotide sequence database under accession no. AJ401618 for blaOCH-1, AJ295340 for
blaOCH-2, AJ295341 for
blaOCH-3, AJ295342 for
blaOCH-4, AJ295343 for
blaOCH-5, AJ295344 for
blaOCH-6, and AJ294345 for
blaOCH-7.
 |
RESULTS |
Antimicrobial agent susceptibility.
The MICs of
-lactams for all strains of O. anthropi showed that
these strains were resistant to all
-lactams tested except imipenem (Table 2). Clavulanic
acid was ineffective and tazobactam slightly reduced resistance to
piperacillin. The E. coli XL1(pBK-OA1) clone and the
E. coli HB101(pSK+-OA2) subclone had similar
resistance phenotypes: resistance to all penicillins (intermediate
resistance to piperacillin in the clone harboring pBK-OA1), resistance
to all cephalosporins except cefepime, intermediate susceptibility to
aztreonam, and susceptibility to imipenem.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
MICs of -lactams for O. anthropi SLO74,
six reference strains of O. anthropi, the E. coli
XL1(pBK-OA1) clone, the E. coli
HB101(pSK+-OA2) subclone, and the strains E. coli XL1 and E. coli HB101
|
|
IEF.
A band of
-lactamase activity was detected
in each strain of O. anthropi in analytical IEF experiments.
The corresponding pI was 8.9 for the parental strain O. anthropi SLO74. The pI values for the six reference strains of
O. anthropi were from 8 to 9.2 (CIP 82113, pI = 9; CIP
83115T, pI = 8; CIP 83116, pI
9.2; CIP 102332, pI
9.2; CIP 103949, pI = 9.2; CIP 103952, pI = 8.5) (data not shown).
Cloning and sequence analysis of blaOCH-1
and subcloning.
Total genomic DNA from O. anthropi SLO74 was digested with EcoRI and inserted
into the EcoRI site of pBK-CMV. Four identical recombinant
E. coli XL1 clones were obtained. One harboring pBK-OA1 (insert, 4.7 kb) was selected for further study. It produced a
-lactamase with a pI of 8.9. The entire 4,743-bp
DNA insert was sequenced on both strands. We found that this
insert contained five open reading frames (ORFs) (Fig.
1). Two ORFs (ORF4 and ORF5) showed no
sequence identity with DNA sequences in databases in BLASTN
searches. ORF1 was 98% identical to a gene encoding a 25-kDa outer membrane protein in Brucella abortus (9).
ORF3 was 1,169 bp long and encoded a 390-amino-acid sequence. This ORF
was preceded by putative
35 (TTGTCG) and
10 (GTATAT) promoter
regions and a putative ATG initiation codon at position 1070 (Fig.
2). The consensus sites, SVSK and KTG,
characteristic of serine
-lactamases were detected in
the deduced amino acid sequence of the protein (17). The
structural element characteristic of class C
-lactamases, YSN (24), was also detected (Fig.
3). The deduced amino acid sequence
(OCH-1) was 42 to 52% identical to those of other chromosomally encoded and plasmid-encoded class C
-lactamases (Fig.
4). Immediately upstream from the
blaOCH-1 gene was ORF2, an 867-bp ORF containing an ampR gene. This ampR gene had an overlapping
and divergently oriented promoter (2): the sequences of
boxes
35 and
10 were AACGCG and GCAATA, and a Lys-R motif
(CTTTTTAAACC) (15, 21) was found (Fig.
2). The deduced amino acid sequence of the AmpR protein showed
this protein to have a helix-turn-helix domain at the N terminus
(15, 21). The AmpR protein of O. anthropi was
46 to 62% identical to other AmpR proteins (Fig.
5).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic restriction endonuclease map of the
recombinant plasmids pBK-OA1 and pSK+-OA2. The genes
ampR and ampC and the other ORFs are indicated.
|
|

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 2.
Nucleotide sequence of the 2,244-bp fragment of pBK-OA1
containing the ampC and ampR coding regions. The
putative promoter sequences are indicated as 35 and 10 regions
(boxed). The start codons and the Lys-R motif are indicated by arrows,
and the stop codons are underlined. The PCR primers upper ochro and
lower ochro are in italics.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 3.
Multiple alignment of AmpC amino acid sequences deduced
from the sequence of the ampC gene present in O. anthropi SLO74 and in the six reference strains of O. anthropi. The specific SVSK and KTG boxes of the serine-active
-lactamases and the KTG box specific for class C
-lactamases are boxed. Identical amino acids are
indicated by dashes.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic dendrogram obtained for 16 representative
chromosomally encoded and plasmid-encoded class C
-lactamases. Percentages in brackets are percent
identities between the indicated amino acid sequence and that of
OCH-1.
|
|

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 5.
Multiple alignment of deduced amino acid sequences of
AmpR, which regulates cephalosporinase genes. The origins of the
AmpR sequences are as follows: 1, E. cloacae MHN-1; 2, Citrobacter freundii OS 60; 3, Yersinia enterocolitica IP97; 4, Morganella
morganii GUI-1; 5, O. anthropi SLO74; 6, P. aeruginosa PAO01; 7, Providencia stuartii VDG 96. Identical amino acids are indicated by an asterisk. The predicted
helix-turn-helix motif (HTH) of the Lys-R family is indicated by
arrows.
|
|
pBK-OA1 was double digested with
SacII and
EcoRI,
and the resulting fragment was inserted into pBC SK
+. The
E. coli HB101 subclone harbored a recombinant plasmid,
pSK
+-OA2. DNA sequencing showed this plasmid to contain an
insert
of 3,141 bp. The
ampC gene (ORF3) and a truncated
ampR gene (ORF2)
were identified in this insert (Fig.
1). This subclone was used
for kinetic measurements for the OCH-1

-lactamase.
Biochemical properties of OCH-1.
The
-lactamase
of O. anthropi produced by the E. coli
HB101(pSK+-OA2) subclone was overproduced, and crude
extracts were found to have a specific activity of about 1,000 mU per
mg. The enzyme was purified and the final preparation of the enzyme was
>90% pure, as shown by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, which was similar to results published for
other class C
-lactamases (5). The
isoelectric point of the enzyme, determined by analytical IEF
(1), was 8.9. This enzyme had a low
kcat for penicillins, a high
kcat for cephalothin and cefaloridine, and
similar kcat values for oxyimino cephalosporins
(Table 3), but the Km measured for cefotaxime
was low (9 µM), whereas those measured for cefepime, cefpirome,
and ceftazidime were high. Aztreonam was a poor substrate, with no
detectable hydrolysis and a high Ki (data not
shown). For cephamycins (cefoxitin and cefotetan), no hydrolysis was
detected, but the Kis were very low (excellent
affinity) (Table 3).
Diversity of the O. anthropi AmpC
-lactamase.
An amplification product of about 1.3 kb was obtained for the six reference strains of O. anthropi. Sequencing of these products showed the ampC
gene to be present in all six. Amino acid sequence analysis showed few
differences (Fig. 3). The percentage of identity was between 96 and
99%.
 |
DISCUSSION |
O. anthropi is a gram-negative, mobile, aerobic,
oxidase-positive, rod-shaped bacterium that often infects
immunocompromised hosts (11, 14). The most frequent
infection due to O. anthropi is central venous
catheter-related bacteremia (10, 18). O. anthropi is generally resistant to all
-lactams except
imipenem (4). The clinical strain SLO74 has this
restoring resistance phenotype. The antimicrobial agent susceptibility
of this strain and of the six reference strains confirmed this
resistance to all
-lactams except imipenem.
-Lactamase inhibitors were inactive (clavulanic acid) or had only
weak activity (tazobactam) in restoring susceptibility to penicillins.
Among the gram-negative bacteria, O. anthropi is the most
resistant to
-lactams (e.g., Stenotrophomonas maltophilia, which in addition is resistant to
carbapenems) (31).
We investigated the cause of this high level of resistance to
-lactams by searching for
-lactamase production.
All strains studied had a
-lactamase with a pI in the
alkaline range (8 to >9.2). The pattern of susceptibility, inactivity
of inhibitors, and alkaline pI suggested the presence of a class C
-lactamase (6). Using total DNA digested
with EcoRI, we obtained four identical recombinant clones.
The E. coli XL1 clone harboring the recombinant plasmid
pBK-OA1 was resistant to all
-lactams (intermediate resistance
to piperacillin and aztreonam) except cefepime and imipenem.
This profile differed from that of the parental strain, O. anthropi SLO74, essentially in the level of resistance to
cefepime. Cefepime is known to be stable and to be unaffected by class
C
-lactamases (29). Therefore, the
resistance to cefepime observed in the parental strain and in the six
reference strains may be due to an impermeability mechanism
(26). Analysis of the DNA sequence of the 4,743-bp insert
of pBK-OA1 showed the presence of a gene with less than 50% identity
to genes encoding class C
-lactamases. The deduced
amino acid sequence contained two sites characteristic of
active-site serine
-lactamases (SXXK and KXG) and a site
characteristic of class C
-lactamases (YXN). The
protein, OCH-1, was 42 to 52% identical to various different chromosomally encoded and plasmid-encoded class C
-lactamases. The highest level of sequence identity to
OCH-1 was recorded with a class C
-lactamase called CepS
(Aeromonas sobria) (32), with 52% identity. It
is a new class C
-lactamase, very distantly related to
other known class C enzymes.
The kinetic parameters of the purified OCH-1
-lactamase
from O. anthropi are typical of class C
-lactamases such as that produced by
Enterobacter cloacae P99 (23). OCH-1 conferred
resistance to all
-lactams except cefepime and imipenem.
The level of resistance to extended-spectrum cephalosporins is high and
comparable to that observed in Enterobacteriaceae
overproducing the chromosomal class C
-lactamase, and it
was therefore not possible to observe the inducible effect of cefoxitin
or imipenem by standard diffusion (2).
Immediately upstream from the ampC gene was a gene in the
opposite orientation that was 45 to 60% identical to known
ampR genes. A helix-turn-helix motif was detected at the
N-terminal end of the deduced amino acid sequence, as observed in other
AmpR proteins and typical of transcriptional activators of the the Lys-R family (15, 21).
Analysis of the intercistronic region showed the presence of a Lys-R
motif. The DNA sequence of this motif displayed a higher level of
identity to the corresponding region in Pseudomonas
aeruginosa PAO01 (22) than in
Enterobacteriaceae (Fig. 6).
This region is very long (193 bp) and is longer than the intercistronic
region present in P. aeruginosa PAO01 (22). The
putative promoters of the ampC and ampR genes
overlapped and were divergently oriented, as previously described for
the ampC-ampR regulatory system
(23).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 6.
Alignment of the ampC-ampR intercistronic
region from the -lactamase of the following strains: 1, O. anthropi SLO74; 2, P. aeruginosa PAO01; 3, P. stuartii VDG 96; 4, M. morganii SLM 01; 5, Y. enterocolitica IP 97; 6, C. freundii OS 60. The Lys-R motif is boxed.
|
|
Comparison of the seven deduced AmpC amino acid sequences from the
parental strain, SLO74, and the six reference strains of O. anthropi showed that there were seven different
-lactamases, with amino acid sequences that were 96 to
99% identical. We obtained seven different pIs, confirming this
observation. These seven
-lactamases are very distantly
related to the other group of class C
-lactamases. The
-lactamase present in strain SLO74 was named OCH-1, and
the others present in the six reference strains of O. anthropi were named OCH-2 (CIP 82113), OCH-3 (CIP 82115T), OCH-4 (CIP 82116), OCH-5 (CIP 102332), OCH-6 (CIP 103949), and OCH-7 (CIP 103952).
 |
ACKNOWLEDGMENTS |
This work was financed by grants from the Ministère de
l'Education Nationale, de la Recherche et de la Technologie
(Réseau
-lactamase), Paris, from the UFR
Saint-Antoine, Paris, and from the Institut Beecham, La Défense, France.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Service de
Bactériologie, Hôpital Tenon, 4, rue de la Chine, 75970 Paris Cedex 20, France. Phone: 33 1 56 01 70 18. Fax: 33 1 56 01 61 08. E-mail: guillaume.arlet{at}tnn.ap-hop-paris.fr.
 |
REFERENCES |
| 1.
|
Barthélémy, M.,
M. Guionie, and R. Labia.
1978.
-Lactamases: determination of their isoelectric points.
Antimicrob. Agents Chemother.
13:695-698[Abstract/Free Full Text].
|
| 2.
|
Bennett, P. M., and I. Chopra.
1993.
Molecular basis of -lactamase induction in bacteria.
Antimicrob. Agents Chemother.
37:153-158[Free Full Text].
|
| 3.
|
Bizet, C., and J. Bizet.
1995.
Sensibilité comparée de Ochrobactrum anthropi, Agrobacterium tumefaciens, Alcaligenes faecalis, Alcaligenes denitrificans subsp. denitrificans, Alcaligenes denitrificans subsp. xylosoxydans et Bordetella bronchiseptica vis-à-vis de 35 antibiotiques dont 17 -lactamamines.
Path. Biol.
43:258-263.
|
| 4.
|
Brivet, F.,
M. Guibert,
M. Kiredjian, and J. Dormont.
1993.
Necrotizing fasciitis, bacteremia, and multiorgan failure caused by Ochrobactrum anthropi.
Clin. Infect. Dis.
17:516-518[Medline].
|
| 5.
|
Bulychev, A., and S. Mobashery.
1999.
Class C -lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates.
Antimicrob. Agents Chemother.
43:1743-1746[Abstract/Free Full Text].
|
| 6.
|
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 7.
|
Cieslak, T. J.,
M. L. Robb,
C. J. Drabick, and G. W. Fischer.
1992.
Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria.
Clin. Infect. Dis.
14:902-907[Medline].
|
| 8.
|
Déliere, E.,
H. Vu-Thien,
V. Levy,
S. Barquins,
L. Schlegel, and A. Bouvet.
2000.
Epidemiological investigation of Ochrobactrum anthropi strains isolated from a haematology unit.
J. Hosp. Infect.
44:173-178[CrossRef][Medline].
|
| 9.
|
de Wergifosse, P.
1995.
Cloning and nucleotide sequence of the gene coding for the 25-kilodalton outer membrane protein of Brucella abortus.
J. Bacteriol.
177:1911-1914[Abstract/Free Full Text].
|
| 10.
|
Earhart, K. C.,
K. Boyce,
W. D. Bone, and M. R. Wallace.
1997.
Ochrobactrum anthropi infection of retained pacemaker leads.
Clin. Infect. Dis.
24:281-282[Medline].
|
| 11.
|
Gill, M. V.,
H. Ly,
M. Mueenuddin,
P. E. Schoch, and B. A. Cunha.
1997.
Intravenous line infection due to Ochrobactrum anthropi (CDC group Vd) in a normal host.
Heart Lung
26:335-336[CrossRef][Medline].
|
| 12.
|
Grandsden, W. R., and S. J. Eykyn.
1992.
Seven cases of bacteremia due to Ochrobactrum anthropi.
Clin. Infect. Dis.
15:1068-1069[Medline].
|
| 13.
|
Grimont, F., and P. A. D. Grimont.
1986.
Ribosomal nucleic acid gene restriction as a potential taxonomic tool.
Ann. Microbiol.
137B:165-175.
|
| 14.
|
Haditsch, M.,
L. Binger,
G. Tschurtschenthaler,
R. Watschinger,
G. Zauner, and H. Mittermayer.
1994.
Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.
Infection
22:291-292[CrossRef][Medline].
|
| 15.
|
Henikoff, S.,
G. W. Haughn,
D. L. Wulff, and J. C. Wallace.
1988.
A large family of bacterial activator proteins.
Proc. Natl. Acad. Sci. USA
85:6602-6606[Abstract/Free Full Text].
|
| 16.
|
Holmes, B.,
M. Popoff,
M. Kiredjian, and K. Kersters.
1988.
Ochrobactrum anthropi gen. nov., sp. nov. from human clinical specimens and previously known as group Vd.
Int. J. Syst. Bacteriol.
38:406-416[Abstract/Free Full Text].
|
| 17.
|
Joris, B.,
J. M. Ghuysen,
G. Dive,
A. Renard,
O. Dideberg,
P. Charlier,
J. M. Frere,
J. A. Kelly,
J. C. Boyington,
P. C. Moews, and J. R. Knox.
1988.
The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family.
Eur. J. Biochem.
250:313-324.
|
| 18.
|
Kern, W. V.,
M. Oethinger,
A. Kaufhold,
E. Rozdzinski, and R. Marre.
1993.
Ochrobactrum anthropi bacteremia: report of four cases and short review.
Infection
21:306-310[CrossRef][Medline].
|
| 19.
|
Klein, J. D., and S. C. Eppes.
1993.
Ochrobactrum anthropi bacteremia in a child.
Del. Med. J.
65:493-495[Medline].
|
| 20.
|
Labia, R.,
J. Andrillon, and F. Le Goffic.
1973.
Computerized microacidimetric determination of -lactamase Michaelis Menten constants.
FEBS Lett.
33:42-44[CrossRef][Medline].
|
| 21.
|
Lindberg, F.,
L. Westman, and S. Normark.
1987.
Regulatory components in Citrobacter freundii ampC -lactamase induction.
Proc. Natl. Acad. Sci. USA
82:4620-4624.
|
| 22.
|
Lodge, J. M.,
S. D. Minchin,
L. J. Piddock, and J. W. Busby.
1990.
Cloning and sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal -lactamase.
Biochem. J.
272:627-631[Medline].
|
| 23.
|
Matagne, A.,
A. Dubus,
M. Galleni, and J. M. Frere.
1999.
The -lactamase cycle: a tale of selective pressure and bacterial ingenuity.
Nat. Prod. Rep.
16:1-19[CrossRef][Medline].
|
| 24.
|
Matsumura, N.,
S. Minami, and S. Mitsuhashi.
1998.
Sequences of homologous -lactamases from clinical isolates of Serratia marcescens with different substrate specificities.
Antimicrob. Agents Chemother.
42:176-179[Abstract/Free Full Text].
|
| 25.
|
Peltroche-Llacsahuanga, H.,
V. Brandenburg,
J. Riehl, and G. Hasse.
2000.
Ochrobactrum anthropi peritonitis in a CAPD patient.
J. Infect.
40:299-301[CrossRef][Medline].
|
| 26.
|
Piddock, L. J., and E. A. Traynor.
1991.
-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
J. Antimicrob. Chemother.
28:209-219[Abstract/Free Full Text].
|
| 27.
|
Roberto, M.,
N. Anna,
F. Morena,
C. Leonardo,
T. Marina, and C. Francesco.
1999.
Ochrobactrum anthropi as an agent of nosocomial septicemia in the setting of AIDS.
Clin. Infect. Dis.
28:692-694[Medline].
|
| 28.
|
Saavedra, J.,
C. Garrido,
D. Folgueira,
M. J. Torres, and J. T. Ramos.
1999.
Ochrobactrum anthropi bacteremia associated with a catheter in an immunocompromised child and review of the pediatric literature.
Pediatr. Infect. Dis. J.
18:586-660.
|
| 29.
|
Sanders, C. C.
1993.
Cefepime: the next generation?
Clin. Infect. Dis.
17:369-379[Medline].
|
| 30.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 31.
|
Spencer, R. C.
1995.
The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
J. Hosp. Infect.
30(Suppl.):453-464.
|
| 32.
|
Walsh, T. R.,
J. Hall,
A. P. MacGowan, and P. M. Bennett.
1995.
Sequence analysis of two chromosomally mediated inducible -lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase.
J. Antimicrob. Chemother.
36:41-52[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, August 2001, p. 2324-2330, Vol. 45, No. 8
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.8.2324-2330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jacoby, G. A.
(2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev.
22: 161-182
[Abstract]
[Full Text]
-
Jacoby, G. A.
(2006). {beta}-Lactamase Nomenclature.. Antimicrob. Agents Chemother.
50: 1123-1129
[Full Text]
-
Teyssier, C., Marchandin, H., Jean-Pierre, H., Diego, I., Darbas, H., Jeannot, J.-L., Gouby, A., Jumas-Bilak, E.
(2005). Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp.. J Med Microbiol
54: 945-953
[Abstract]
[Full Text]
-
Lau, S. K. P., Ho, P.-l., Li, M. W. S., Tsoi, H.-w., Yung, R. W. H., Woo, P. C. Y., Yuen, K.-y.
(2005). Cloning and Characterization of a Chromosomal Class C {beta}-Lactamase and Its Regulatory Gene in Laribacter hongkongensis. Antimicrob. Agents Chemother.
49: 1957-1964
[Abstract]
[Full Text]
-
Beauchef-Havard, A., Arlet, G., Gautier, V., Labia, R., Grimont, P., Philippon, A.
(2003). Molecular and Biochemical Characterization of a Novel Class A {beta}-Lactamase (HER-1) from Escherichia hermannii. Antimicrob. Agents Chemother.
47: 2669-2673
[Abstract]
[Full Text]
-
Kettaneh, A., Weill, F.-X., Poilane, I., Fain, O., Thomas, M., Herrmann, J.-L., Hocqueloux, L.
(2003). Septic Shock Caused by Ochrobactrum anthropi in an Otherwise Healthy Host. J. Clin. Microbiol.
41: 1339-1341
[Abstract]
[Full Text]